NasdaqGM - Delayed Quote • USD
Merus N.V. (MRUS)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:01 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 12 |
| Avg. Estimate | -0.81 | -0.84 | -3.23 | -3.28 |
| Low Estimate | -1.09 | -1.25 | -3.68 | -3.78 |
| High Estimate | -0.61 | -0.67 | -2.65 | -2.19 |
| Year Ago EPS | -0.86 | -0.66 | -3 | -3.23 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 13 | 12 |
| Avg. Estimate | 9.74M | 9.32M | 41.38M | 65M |
| Low Estimate | 3M | 3M | 10M | 28.17M |
| High Estimate | 13.33M | 13.04M | 60.59M | 114.54M |
| Year Ago Sales | 13.5M | 10.48M | 43.95M | 41.38M |
| Sales Growth (year/est) | -27.80% | -11.00% | -5.80% | 57.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.02 | -0.88 | -0.73 | -0.74 |
| EPS Actual | -0.86 | -0.66 | -0.43 | -1.04 |
| Difference | 0.16 | 0.22 | 0.3 | -0.3 |
| Surprise % | 15.70% | 25.00% | 41.10% | -40.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.81 | -0.84 | -3.23 | -3.28 |
| 7 Days Ago | -0.81 | -0.85 | -3.24 | -3.29 |
| 30 Days Ago | -0.78 | -0.81 | -3.27 | -3.49 |
| 60 Days Ago | -0.75 | -0.77 | -3.14 | -3.38 |
| 90 Days Ago | -0.72 | -0.73 | -3.06 | -3.28 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MRUS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 5.80% | -- | -- | 1.60% |
| Next Qtr. | -27.30% | -- | -- | 10.50% |
| Current Year | -7.70% | -- | -- | 5.20% |
| Next Year | -1.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/11/2024 |
| Initiated | Truist Securities: Buy | 3/28/2024 |
| Maintains | Needham: Buy to Buy | 3/7/2024 |
| Maintains | Needham: Buy to Buy | 3/4/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/29/2024 |
| Maintains | Stifel: Buy to Buy | 2/29/2024 |
Related Tickers
CRNX Crinetics Pharmaceuticals, Inc.
42.97
-0.09%
IDYA IDEAYA Biosciences, Inc.
37.13
-1.30%
SNDX Syndax Pharmaceuticals, Inc.
20.80
+1.51%
KRYS Krystal Biotech, Inc.
158.53
-3.32%
NUVL Nuvalent, Inc.
62.76
-0.48%
REPL Replimune Group, Inc.
6.45
-7.46%
ANAB AnaptysBio, Inc.
19.87
+0.20%
IMCR Immunocore Holdings plc
55.68
+1.72%
XNCR Xencor, Inc.
18.38
-3.01%
MOR MorphoSys AG
17.98
-0.39%